Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Cardio-Oncology (London, England)|March 9, 2023
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapyAnthony F Yu, Chau T Dang, Justine Jorgensen, et al.Breast Cancer Research and Treatment|January 2, 2015
Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancerAnthony F Yu, Nandini U Yadav, Betty Y Lung, et al.Clinical Imaging|February 10, 2020
Diagnostic utility and clinical implication of late gadolinium enhancement cardiac magnetic resonance for detection of catheter associated right atrial thrombusAndrew J Plodkowski, Angel Chan, Dipti Gupta, et al.The Oncologist|March 30, 2018
Development and Validation of a Clinical Score for Cardiovascular Risk Stratification of Long-Term Childhood Cancer SurvivorsEvangelos K Oikonomou, Sofia G Athanasopoulou, Polydoros N Kampaktsis, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 8, 2017
Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell TransplantationShawn C Pun, Heather J Landau, Elyn R Riedel, et al.The Oncologist|March 26, 2017
Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast CancerAnthony F Yu, Jasmeet C Singh, Rui Wang, et al.JACC. Cardiooncology|October 29, 2020
Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL AmyloidosisKatherine Lee Chuy, Esther Drill, Ji Can Yang, et al.JAMA Cardiology|May 31, 2023
Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Treatment for ERBB2-Positive Breast CancerAnthony F Yu, Zachary R Moore, Chaya S Moskowitz, et al.The Oncologist|August 5, 2015
Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular DysfunctionAnthony F Yu, Nandini U Yadav, Anne A Eaton, et al.Journal of the American College of Cardiology|October 29, 2021
Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell TherapyAdam Goldman, Elad Maor, David Bomze, et al.Pageof 6